Abstract:Objective . The aim of this study was to explore the calcification process of aortic valve interstitial cells and its potential association with osteogenic differentiation and alkaline phosphatase (ALP) activity. Methods . The study patients were divided into 3 groups: the control group, the osteogenic induction medium (OM) group and the OM+ALP inhibitor group. Cell calcification was measured by alizarin red S staining and alizarin red S dye released by extracellular matrix (ECM) was quantified by spectrophotometry. Immunohistochemical staining was performed on valve tissues of patients harboring calcified and non-calcified aortic valve disease. Expression of bone morphogenetic protein (BMP), runt related transcription factor 2 (RUNX2), osteocalcin and osteopontin (OPN), was evaluated using immunohistochemistry, and expression of osteogenic specific markers (BMP, RUNX2 and OPN) was detected using Wesern blot analysis. RNA sequencing was analyzed to further study the exact mechanism of ALP inhibitors in terms of inhibiting the osteogenic differentiation of valvular interstitial cells (VIC). The mRNA levels of tumor necrosis factor alpha (TNF-alpha), Toll-like receptor 4 (TLR4) and NOD-like receptor thermal protein domain associated protein 3 (NLRP3), were detected using reverse-transcription quantitative polymerase chain reaction (RT-qPCR). In addition, Western blot analysis was performed to evaluate the expression of phosphorylated extracellular regulated protein kinases (ERK), nuclear factor kappa B inhibitor alpha (I kappa B alpha) and protein kinase B (AKT) in protein. Results . Alizarin red staining was positive in the OM and OM+ALP inhibitor groups, and calcified nodules were formed in VIC, which showed a significant difference compared with the control group (P <.05). The semi-quantitative level of calcification in the OM group was higher than in the control group (P <.05), and the semiquantitative level of calcification in the OM+ALP inhibitor group was lower than in the OM group (P <.05). ALP staining intensity, ALP activity and messenger RNA (mRNA) levels of BMP, RUNX2, osteocalcin, OPN, ERK, I kappa B alpha, AKT, TNF-alpha, Toll-like receptor 4 (TLR4) and NLRP3 inflammasome (NLRP3) in the OM group were higher than in the control group (P <.05). ALP staining intensity, ALP activity and mRNA expressions of BMP, RUNX2, osteocalcin, OPN, phosphorylated ERK, I kappa B alpha, AKT, TNF-alpha and NLRP3 in the OM+ALP inhibitor group were lower than in the OM group (P <.05). Compared with the control group, 723 genes were upregulated and 248 genes were downregulated in the OM group. Compared with the OM group, 352 genes were upregulated and 586 genes were downregulated in the OM+ALP inhibitor group. Conclusion . We suggest that ALP inhibitors have potential in terms of inhibiting the inflammatory response and osteoblast differentiation of human VIC (hVIC) via the TLR4, AKT, ERK and NLRP3 pathways.

Inhibition of PP2A enhances the osteogenic differentiation of human aortic valvular interstitial cells via ERK and p38 MAPK pathways

PTP1B Inhibition Improves Mitochondrial Dynamics to Alleviate Calcific Aortic Valve Disease Via Regulating OPA1 Homeostasis.

Histone Deacetylase 6 Reduction Promotes Aortic Valve Calcification Via an Endoplasmic Reticulum Stress-Mediated Osteogenic Pathway.

Knockdown of Estrogen‐related Receptor Α Inhibits Valve Interstitial Cell Calcification in Vitro by Regulating Heme Oxygenase 1

Deficiency of CCAAT/enhancer-binding Protein Homologous Protein (CHOP) Prevents Diet-Induced Aortic Valve Calcification in Vivo

Platelet Membrane-Coated Alterbrassicene a Nanoparticle Inhibits Calcification of the Aortic Valve by Suppressing Phosphorylation P65 NF-κB

Role of TGF-β1 Signaling in Heart Valve Calcification Induced by Abnormal Mechanical Stimulation in a Tissue Engineering Model

Caffeic Acid Phenethyl Ester Ameliorates Calcification by Inhibiting Activation of the AKT/NF-κB/NLRP3 Inflammasome Pathway in Human Aortic Valve Interstitial Cells

ALP Inhibitors Inhibit Inflammatory Responses and Osteoblast Differentiation in hVIC via AKT-ERK Pathways

Berberine inhibits osteogenic differentiation of aortic valve interstitial cells by interfering Smad1/5/8 and NF-κB pathways

Human Antigen R Regulates Autophagic Flux by Stabilizing Autophagy-Associated Mrna in Calcific Aortic Valve Disease.

Inorganic Phosphate-Osteogenic Induction Medium Promotes Osteogenic Differentiation of Valvular Interstitial Cells Via the BMP-2/Smad1/5/9 and RhoA/ROCK-1 Signaling Pathways.

MicroRNA-34c Inhibits Osteogenic Differentiation and Valvular Interstitial Cell Calcification via STC1-Mediated JNK Pathway in Calcific Aortic Valve Disease

MiR-138-5p targets RUNX2 to inhibit osteogenic differentiation of aortic valve interstitial cells via Wnt/β-catenin signaling pathway

The role of neutrophil elastase in aortic valve calcification

The Effect of Oxldl on Aortic Valve Calcification Via the Wnt/ Β-Catenin Signaling Pathway: an Important Molecular Mechanism.

Aldo-keto reductase family 1 member B induces aortic valve calcification by activating hippo signaling in valvular interstitial cells

Overexpression of microRNA-93-5p and microRNA-374a-5p suppresses the osteogenic differentiation and mineralization of human aortic valvular interstitial cells via the BMP2/Smad1/5/RUNX2 signaling pathway

Purinergic Signaling in Pathologic Osteogenic Differentiation of Aortic Valve Interstitial Cells from Patients with Aortic Valve Calcification

Resveratrol Exhibits Inhibition Effects on Osteogenic Differentiation of Aortic Valve Interstitial Cells by Interfering with the AKT Pathway

Inhibition of PP2A Ameliorates Intervertebral Disc Degeneration by Reducing Annulus Fibrosus Cells Apoptosis Via P38/mapk Signal Pathway.